VALSARTAN ORAL

VALSARTAN ORAL was reported 55108 times

VALSARTAN ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FEMORAL HERNIA INCARCERATED 46 0.6389
1 LYMPHATIC FISTULA 45 0.4500
2 VAGINAL FLATULENCE 125 0.4125
3 BRONCHIAL NEOPLASM 50 0.3676
4 CRANIAL SUTURES WIDENING 41 0.2971
5 MERYCISM 56 0.1958
6 PRODUCT IMPURITY 51 0.1861
7 PANCREATIC STEATOSIS 47 0.1728
8 BRONCHIAL HAEMORRHAGE 52 0.1667
9 CONGENITAL RENAL DISORDER 41 0.1541
10 WOUND INFECTION PSEUDOMONAS 45 0.1438
11 TISSUE INFILTRATION 41 0.1390
12 NASAL TURBINATE HYPERTROPHY 52 0.1379
13 ENDOMETRIAL ABLATION 49 0.1373
14 PHYSICAL DECONDITIONING 269 0.1044
15 FOETAL DISORDER 86 0.1029
16 MULTIPLE DRUG THERAPY 62 0.0822
17 FEMALE GENITAL TRACT FISTULA 136 0.0796
18 FEAR OF DISEASE 135 0.0758
19 OLIGOHYDRAMNIOS 251 0.0752
20 PULMONARY HYPOPLASIA 58 0.0736
21 MULTI-ORGAN DISORDER 143 0.0726
22 OSTEOCHONDROSIS 80 0.0689
23 MACULAR DEGENERATION 816 0.0683
24 BRASH SYNDROME 79 0.0563
25 ORTHOSTATIC INTOLERANCE 40 0.0557
26 RHONCHI 75 0.0543
27 ADENOMA BENIGN 45 0.0523
28 CAROTID ARTERIOSCLEROSIS 54 0.0523
29 RADICULOPATHY 138 0.0523
30 CHRONIC SINUSITIS 192 0.0511
31 HYPOCHROMIC ANAEMIA 50 0.0493
32 PROCTITIS 132 0.0471
33 ARTERIAL HAEMORRHAGE 53 0.0464
34 OBSTRUCTIVE SLEEP APNOEA SYNDROME 63 0.0432
35 BLOOD PRESSURE INADEQUATELY CONTROLLED 243 0.0404
36 LYMPHOCYTE COUNT ABNORMAL 45 0.0400
37 SEROMA 50 0.0393
38 RENAL NEOPLASM 80 0.0377
39 MAJOR DEPRESSION 272 0.0372
40 NEPHROGENIC ANAEMIA 167 0.0360
41 ANXIETY DISORDER 120 0.0359
42 BRONCHIAL DISORDER 55 0.0353
43 AORTIC DILATATION 39 0.0351
44 CARDIAC FAILURE CHRONIC 143 0.0335
45 PANCREATIC NEOPLASM 39 0.0315
46 COLITIS MICROSCOPIC 149 0.0314
47 AORTIC VALVE STENOSIS 56 0.0314
48 PRODUCT CONTAMINATION 109 0.0306
49 DIVERTICULUM INTESTINAL 133 0.0304
50 HYPERPARATHYROIDISM SECONDARY 75 0.0299
51 AORTIC ARTERIOSCLEROSIS 77 0.0299
52 BUNDLE BRANCH BLOCK LEFT 124 0.0292
53 SINUS ARREST 44 0.0280
54 TACHYARRHYTHMIA 68 0.0272
55 HEPATIC CYST 86 0.0253
56 RENAL CYST 196 0.0247
57 KYPHOSIS 43 0.0243
58 HYPERTENSIVE HEART DISEASE 45 0.0240
59 RECALLED PRODUCT ADMINISTERED 229 0.0240
60 HYPERTENSIVE CRISIS 265 0.0238
61 DIASTOLIC DYSFUNCTION 72 0.0233
62 FORCED EXPIRATORY VOLUME DECREASED 65 0.0229
63 LEFT VENTRICULAR HYPERTROPHY 97 0.0226
64 MITRAL VALVE INCOMPETENCE 255 0.0225
65 TRICUSPID VALVE INCOMPETENCE 178 0.0224
66 CHRONIC GASTRITIS 50 0.0221
67 REBOUND ACID HYPERSECRETION 65 0.0215
68 AORTIC VALVE INCOMPETENCE 89 0.0209
69 DISTRIBUTIVE SHOCK 47 0.0207
70 HYPERKALAEMIA 725 0.0207
71 ACTINIC KERATOSIS 53 0.0204
72 GOITRE 81 0.0198
73 THYROID DISORDER 301 0.0195
74 BLOOD PRESSURE SYSTOLIC ABNORMAL 48 0.0194
75 BLOOD PRESSURE DIASTOLIC DECREASED 143 0.0194
76 OBSTRUCTIVE AIRWAYS DISORDER 215 0.0193
77 LEFT VENTRICULAR DYSFUNCTION 129 0.0192
78 HAEMANGIOMA 44 0.0190
79 BLOOD PRESSURE DIASTOLIC ABNORMAL 48 0.0189
80 HYPERURICAEMIA 77 0.0187
81 EXERCISE TOLERANCE DECREASED 107 0.0186
82 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 75 0.0184
83 SEROTONIN SYNDROME 351 0.0183
84 INGUINAL HERNIA 111 0.0182
85 BLOOD PRESSURE SYSTOLIC INCREASED 353 0.0181
86 ARTERIOSCLEROSIS CORONARY ARTERY 118 0.0178
87 BREATH SOUNDS ABNORMAL 86 0.0174
88 MALNUTRITION 195 0.0174
89 ORTHOPNOEA 55 0.0173
90 DYSPNOEA AT REST 50 0.0172
91 WOUND DEHISCENCE 58 0.0171
92 VENTRICULAR HYPOKINESIA 55 0.0171
93 GRANULOMA 59 0.0170
94 GLOMERULAR FILTRATION RATE DECREASED 209 0.0170
95 IRON DEFICIENCY 76 0.0169
96 METABOLIC ACIDOSIS 534 0.0167
97 RENAL CELL CARCINOMA 80 0.0163
98 HYPONATRAEMIA 917 0.0163
99 ERYSIPELAS 81 0.0161
100 ACUTE KIDNEY INJURY 2441 0.0159
101 INTERVERTEBRAL DISC DISORDER 68 0.0159
102 BENIGN PROSTATIC HYPERPLASIA 82 0.0159
103 DYSLIPIDAEMIA 80 0.0157
104 MELANOCYTIC NAEVUS 69 0.0157
105 GASTROINTESTINAL STROMAL TUMOUR 41 0.0154
106 PARAESTHESIA ORAL 222 0.0154
107 ASTHMATIC CRISIS 56 0.0153
108 HIATUS HERNIA 198 0.0153
109 ANURIA 130 0.0151
110 SNORING 57 0.0151
111 EYE HAEMORRHAGE 201 0.0150
112 GASTRITIS EROSIVE 70 0.0150
113 ARTERIOSCLEROSIS 141 0.0150
114 INFLAMMATORY MARKER INCREASED 74 0.0149
115 END STAGE RENAL DISEASE 272 0.0149
116 SPINAL OSTEOARTHRITIS 131 0.0149
117 LEFT VENTRICULAR FAILURE 51 0.0148
118 ABDOMINAL TENDERNESS 73 0.0147
119 ORAL CANDIDIASIS 192 0.0146
120 RED CELL DISTRIBUTION WIDTH INCREASED 60 0.0144
121 BUNDLE BRANCH BLOCK RIGHT 65 0.0141
122 PULMONARY PAIN 41 0.0140
123 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 124 0.0140
124 VENTRICULAR EXTRASYSTOLES 144 0.0139
125 QUALITY OF LIFE DECREASED 186 0.0138
126 RALES 77 0.0132
127 NOCTURIA 159 0.0131
128 PATENT DUCTUS ARTERIOSUS 52 0.0131
129 VAGINAL DISCHARGE 132 0.0130
130 BRAIN NATRIURETIC PEPTIDE INCREASED 40 0.0130
131 CARDIAC FAILURE ACUTE 86 0.0129
132 DYSPNOEA EXERTIONAL 485 0.0129
133 CUTANEOUS VASCULITIS 47 0.0129
134 VENTRICULAR ARRHYTHMIA 47 0.0128
135 CHRONIC KIDNEY DISEASE 971 0.0128
136 AORTIC ANEURYSM 97 0.0127
137 ATRIOVENTRICULAR BLOCK FIRST DEGREE 55 0.0127
138 FAECALOMA 69 0.0126
139 BLOOD PRESSURE SYSTOLIC DECREASED 57 0.0125
140 CORONARY ARTERY STENOSIS 62 0.0123
141 PANIC DISORDER 47 0.0121
142 EJECTION FRACTION DECREASED 188 0.0121
143 BLOOD PRESSURE FLUCTUATION 289 0.0120
144 IRON DEFICIENCY ANAEMIA 111 0.0120
145 POTENTIATING DRUG INTERACTION 40 0.0119
146 IDIOPATHIC PULMONARY FIBROSIS 47 0.0119
147 HEPATIC STEATOSIS 221 0.0119
148 ATRIOVENTRICULAR BLOCK COMPLETE 79 0.0118
149 SENSITIVITY TO WEATHER CHANGE 62 0.0118
150 DIABETES MELLITUS INADEQUATE CONTROL 206 0.0116
151 RHINITIS 93 0.0115
152 BLOOD PRESSURE ABNORMAL 229 0.0115
153 BLOOD PRESSURE INCREASED 1750 0.0114
154 BLOOD URIC ACID INCREASED 66 0.0114
155 VARICOSE VEIN 59 0.0114
156 POSTOPERATIVE WOUND INFECTION 77 0.0114
157 CONCOMITANT DISEASE AGGRAVATED 70 0.0113
158 PULMONARY OEDEMA 507 0.0113
159 CARDIAC FAILURE 901 0.0112
160 RENAL TUBULAR NECROSIS 110 0.0112
161 HAEMATOMA 290 0.0112
162 PERICARDIAL EFFUSION 257 0.0111
163 HYPERCHOLESTEROLAEMIA 107 0.0111
164 ANGINA PECTORIS 316 0.0110
165 PERIPHERAL VENOUS DISEASE 45 0.0110
166 APLASTIC ANAEMIA 57 0.0109
167 DIVERTICULITIS 302 0.0109
168 KLEBSIELLA INFECTION 55 0.0109
169 GLAUCOMA 209 0.0108
170 ATRIAL FLUTTER 86 0.0108
171 BLOOD UREA INCREASED 180 0.0107
172 HYPOKALAEMIA 496 0.0107
173 PEMPHIGOID 81 0.0107
174 CARDIOGENIC SHOCK 153 0.0107
175 BLOOD PRESSURE DIASTOLIC INCREASED 49 0.0106
176 MONOPLEGIA 46 0.0106
177 OBESITY 168 0.0105
178 DRUG INTERACTION 1668 0.0105
179 CREATININE RENAL CLEARANCE DECREASED 42 0.0105
180 HYPOVOLAEMIA 61 0.0104
181 HYPERVENTILATION 60 0.0103
182 POLYNEUROPATHY 123 0.0103
183 SLEEP APNOEA SYNDROME 196 0.0103
184 POLYARTHRITIS 54 0.0102
185 OSTEOARTHRITIS 431 0.0102
186 POLYURIA 83 0.0101
187 VENTRICULAR SEPTAL DEFECT 58 0.0101
188 CIRCULATORY COLLAPSE 172 0.0101
189 SHOCK HAEMORRHAGIC 82 0.0101
190 JOINT DISLOCATION 106 0.0100
191 GROIN PAIN 88 0.0100
192 ATRIAL FIBRILLATION 974 0.0100
193 GLUCOSE TOLERANCE IMPAIRED 59 0.0100
194 SYNOVITIS 179 0.0099
195 RESPIRATORY RATE INCREASED 88 0.0099
196 CONTRAINDICATED PRODUCT ADMINISTERED 298 0.0098
197 HYPOMAGNESAEMIA 137 0.0098
198 ATRIOVENTRICULAR BLOCK 76 0.0098
199 CARDIOMEGALY 120 0.0097
200 BASAL CELL CARCINOMA 152 0.0097
201 BRADYCARDIA 516 0.0097
202 LACTIC ACIDOSIS 315 0.0097
203 HYPERTENSION 2059 0.0097
204 BLOOD POTASSIUM INCREASED 157 0.0097
205 C-REACTIVE PROTEIN ABNORMAL 62 0.0097
206 TUBULOINTERSTITIAL NEPHRITIS 181 0.0096
207 NEPHROPATHY 90 0.0096
208 C-REACTIVE PROTEIN INCREASED 350 0.0096
209 SPINAL PAIN 111 0.0095
210 MENISCUS INJURY 58 0.0094
211 LYMPHOEDEMA 65 0.0094
212 HYPERLIPIDAEMIA 112 0.0094
213 DUODENAL ULCER 66 0.0093
214 BLOOD CREATININE INCREASED 608 0.0093
215 CORONARY ARTERY DISEASE 281 0.0093
216 PROCEDURAL PAIN 257 0.0093
217 CHOKING SENSATION 51 0.0092
218 BODY TEMPERATURE DECREASED 91 0.0092
219 GOUT 165 0.0092
220 OEDEMA PERIPHERAL 1116 0.0091
221 MYOCARDIAL ISCHAEMIA 103 0.0090
222 TENDON DISORDER 59 0.0090
223 MELAENA 199 0.0090
224 STRESS CARDIOMYOPATHY 52 0.0089
225 SPRUE-LIKE ENTEROPATHY 44 0.0089
226 VENTRICULAR TACHYCARDIA 147 0.0089
227 SYNOVIAL CYST 41 0.0089
228 HAEMATOCHEZIA 490 0.0089
229 LIPASE INCREASED 68 0.0089
230 RENAL IMPAIRMENT 743 0.0088
231 ATRIAL SEPTAL DEFECT 74 0.0088
232 LARGE INTESTINE POLYP 61 0.0088
233 HAEMORRHOIDAL HAEMORRHAGE 43 0.0088
234 FAECES SOFT 64 0.0088
235 ARRHYTHMIA 414 0.0087
236 RESPIRATION ABNORMAL 60 0.0087
237 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 44 0.0087
238 SINUS BRADYCARDIA 84 0.0087
239 PRODUCTIVE COUGH 414 0.0087
240 GASTROENTERITIS 126 0.0086
241 HYPOTHYROIDISM 275 0.0086
242 BODY HEIGHT DECREASED 92 0.0086
243 RENAL FAILURE 1140 0.0086
244 DIVERTICULUM 61 0.0086
245 OLIGURIA 53 0.0085
246 PROTEINURIA 162 0.0085
247 ACUTE MYOCARDIAL INFARCTION 251 0.0085
248 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 87 0.0085
249 GENERAL PHYSICAL HEALTH DETERIORATION 980 0.0085
250 RHABDOMYOLYSIS 353 0.0085
251 HYPOTENSION 1694 0.0084
252 PROTEIN URINE PRESENT 42 0.0084
253 FEMORAL NECK FRACTURE 43 0.0084
254 UPPER GASTROINTESTINAL HAEMORRHAGE 141 0.0084
255 SYNCOPE 838 0.0084
256 AFFECTIVE DISORDER 65 0.0083
257 PULMONARY HYPERTENSION 172 0.0082
258 SINUS TACHYCARDIA 117 0.0082
259 VENTRICULAR FIBRILLATION 91 0.0082
260 PULMONARY CONGESTION 108 0.0082
261 HAEMORRHAGIC STROKE 63 0.0081
262 COLON CANCER 120 0.0080
263 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 41 0.0080
264 CEREBRAL ISCHAEMIA 41 0.0080
265 FREQUENT BOWEL MOVEMENTS 215 0.0080
266 ESCHERICHIA INFECTION 65 0.0079
267 HYPERVOLAEMIA 39 0.0079
268 SKIN REACTION 111 0.0079
269 PRESYNCOPE 191 0.0078
270 HYPERKERATOSIS 43 0.0078
271 HAEMORRHOIDS 152 0.0078
272 SHOCK 179 0.0078
273 UPPER-AIRWAY COUGH SYNDROME 64 0.0078
274 BLOOD SODIUM DECREASED 146 0.0077
275 TOXIC SKIN ERUPTION 78 0.0077
276 SPUTUM DISCOLOURED 73 0.0077
277 UROSEPSIS 71 0.0077
278 PROTHROMBIN TIME PROLONGED 46 0.0077
279 ANAL INCONTINENCE 69 0.0077
280 MALABSORPTION 40 0.0077
281 PHARYNGITIS 95 0.0077
282 FAECES DISCOLOURED 166 0.0076
283 CEREBRAL INFARCTION 186 0.0076
284 SPLENOMEGALY 89 0.0076
285 IMPAIRED QUALITY OF LIFE 109 0.0076
286 PERIPHERAL VASCULAR DISORDER 39 0.0076
287 ORTHOSTATIC HYPOTENSION 131 0.0075
288 NEUTROPHIL COUNT INCREASED 77 0.0075
289 ANAEMIA 1430 0.0075
290 ACUTE CORONARY SYNDROME 62 0.0075
291 CHOLECYSTITIS 89 0.0075
292 MALIGNANT MELANOMA 100 0.0075
293 NEPHROTIC SYNDROME 51 0.0074
294 SCOLIOSIS 46 0.0074
295 CHOLESTASIS 142 0.0074
296 RECTAL HAEMORRHAGE 317 0.0074
297 CORONARY ARTERY OCCLUSION 101 0.0074
298 METASTASES TO LUNG 85 0.0073
299 GAMMA-GLUTAMYLTRANSFERASE INCREASED 163 0.0073
300 HYPERGLYCAEMIA 268 0.0073
301 APHTHOUS ULCER 57 0.0073
302 RENAL FAILURE CHRONIC 56 0.0073
303 WALKING AID USER 48 0.0073
304 HAEMATURIA 249 0.0073
305 HYPERTHYROIDISM 105 0.0072
306 DRUG LEVEL INCREASED 120 0.0072
307 EOSINOPHILIA 127 0.0072
308 INTERVERTEBRAL DISC DEGENERATION 67 0.0072
309 CARDIAC FAILURE CONGESTIVE 581 0.0072
310 ANGINA UNSTABLE 47 0.0072
311 URINE OUTPUT DECREASED 63 0.0072
312 DYSURIA 265 0.0072
313 ENTERITIS 46 0.0072
314 POISONING DELIBERATE 68 0.0072
315 CARDIOVASCULAR DISORDER 182 0.0072
316 MUSCULOSKELETAL DISCOMFORT 122 0.0071
317 HYPOCALCAEMIA 134 0.0071
318 COLITIS 268 0.0071
319 BRONCHITIS 523 0.0071
320 HAEMARTHROSIS 63 0.0070
321 HEPATOMEGALY 69 0.0070
322 TENDERNESS 73 0.0070
323 ISCHAEMIC STROKE 124 0.0069
324 HYPOALBUMINAEMIA 54 0.0069
325 ACIDOSIS 53 0.0069
326 HEART RATE DECREASED 243 0.0069
327 HYPOGLYCAEMIA 335 0.0069
328 RENAL INJURY 205 0.0069
329 UNRESPONSIVE TO STIMULI 178 0.0069
330 DECREASED ACTIVITY 74 0.0069
331 PRODUCT PRESCRIBING ERROR 163 0.0068
332 ELECTROLYTE IMBALANCE 79 0.0068
333 ANKLE FRACTURE 105 0.0068
334 RED BLOOD CELL SEDIMENTATION RATE INCREASED 75 0.0068
335 SUICIDE ATTEMPT 409 0.0067
336 METASTASES TO LIVER 118 0.0067
337 URINARY RETENTION 224 0.0067
338 HAEMATOCRIT DECREASED 133 0.0067
339 HEPATOCELLULAR INJURY 95 0.0067
340 PULMONARY THROMBOSIS 73 0.0067
341 BLOOD PRESSURE DECREASED 444 0.0067
342 HYPOKINESIA 97 0.0067
343 FOOT DEFORMITY 74 0.0067
344 BOWEL MOVEMENT IRREGULARITY 51 0.0067
345 HYPOTONIA 66 0.0066
346 ARTHRITIS 520 0.0066
347 HEAD DISCOMFORT 117 0.0066
348 CARDIAC MURMUR 57 0.0066
349 RENAL FAILURE ACUTE 278 0.0065
350 INTERSTITIAL LUNG DISEASE 317 0.0065
351 BLOOD CREATINE PHOSPHOKINASE INCREASED 188 0.0065
352 ELECTROCARDIOGRAM ABNORMAL 51 0.0065
353 MICTURITION URGENCY 74 0.0065
354 MYOSITIS 58 0.0065
355 PANCREATITIS ACUTE 145 0.0064
356 PERIPHERAL SWELLING 992 0.0064
357 INCONTINENCE 68 0.0064
358 BURSITIS 78 0.0064
359 OXYGEN SATURATION DECREASED 359 0.0064
360 DYSPEPSIA 627 0.0064
361 MIDDLE INSOMNIA 119 0.0064
362 SUBDURAL HAEMATOMA 91 0.0064
363 ERUCTATION 123 0.0064
364 MENTAL IMPAIRMENT 154 0.0063
365 DEHYDRATION 846 0.0063
366 RESPIRATORY TRACT INFECTION 165 0.0063
367 PLEURAL EFFUSION 385 0.0063
368 ALTERED STATE OF CONSCIOUSNESS 137 0.0063
369 HYPOTHERMIA 64 0.0063
370 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 328 0.0063
371 CARPAL TUNNEL SYNDROME 88 0.0063
372 HEPATIC CANCER 151 0.0063
373 URINARY INCONTINENCE 185 0.0062
374 BLOOD TEST ABNORMAL 87 0.0062
375 SLEEP DISORDER 435 0.0062
376 MYOPATHY 53 0.0061
377 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 436 0.0061
378 BLOOD POTASSIUM DECREASED 184 0.0061
379 PERIPHERAL COLDNESS 84 0.0061
380 MUSCLE SPASTICITY 75 0.0061
381 LOWER GASTROINTESTINAL HAEMORRHAGE 45 0.0061
382 SUBARACHNOID HAEMORRHAGE 62 0.0061
383 GASTRITIS 160 0.0061
384 COUGH 1705 0.0061
385 METASTASES TO LYMPH NODES 41 0.0061
386 LOW DENSITY LIPOPROTEIN INCREASED 47 0.0061
387 BLOOD LACTATE DEHYDROGENASE INCREASED 96 0.0061
388 TACHYPNOEA 82 0.0060
389 PROSTATIC SPECIFIC ANTIGEN INCREASED 83 0.0060
390 SCIATICA 96 0.0060
391 VERTIGO 367 0.0060
392 INTENTIONAL OVERDOSE 384 0.0060
393 WHEEZING 354 0.0060
394 BLOOD GLUCOSE ABNORMAL 110 0.0059
395 JOINT EFFUSION 41 0.0059
396 FRUSTRATION TOLERANCE DECREASED 48 0.0059
397 MUSCLE ATROPHY 75 0.0059
398 POLLAKIURIA 246 0.0059
399 INFLAMMATION 304 0.0059
400 ACUTE RESPIRATORY FAILURE 113 0.0059
401 BLOOD CALCIUM DECREASED 66 0.0059
402 FLANK PAIN 55 0.0059
403 LYMPHADENOPATHY 207 0.0058
404 MYOCARDITIS 67 0.0058
405 PULMONARY FIBROSIS 112 0.0058
406 OEDEMA 316 0.0058
407 TINNITUS 267 0.0058
408 TENDON PAIN 44 0.0058
409 ANGIOEDEMA 257 0.0058
410 WEIGHT DECREASED 1620 0.0058
411 MUSCLE STRAIN 50 0.0058
412 DIABETES MELLITUS 440 0.0058
413 DRUG-INDUCED LIVER INJURY 181 0.0058
414 ASPHYXIA 47 0.0058
415 GASTROOESOPHAGEAL REFLUX DISEASE 463 0.0057
416 EMPHYSEMA 58 0.0057
417 SUPRAVENTRICULAR TACHYCARDIA 55 0.0057
418 METASTASIS 41 0.0057
419 MUSCLE TIGHTNESS 93 0.0057
420 FEAR 154 0.0057
421 CHEST PAIN 1060 0.0057
422 RESTLESSNESS 208 0.0057
423 PRODUCT SUBSTITUTION ISSUE 327 0.0057
424 DIZZINESS 2828 0.0057
425 TENDON RUPTURE 70 0.0057
426 SEASONAL ALLERGY 80 0.0056
427 MYALGIA 958 0.0056
428 LARGE INTESTINE PERFORATION 39 0.0056
429 CEREBRAL HAEMORRHAGE 201 0.0056
430 URINARY TRACT INFECTION 955 0.0056
431 SOPOR 74 0.0056
432 INTERVERTEBRAL DISC PROTRUSION 122 0.0056
433 IMPAIRED GASTRIC EMPTYING 76 0.0056
434 CONTUSION 536 0.0056
435 BLOOD MAGNESIUM DECREASED 48 0.0056
436 BLOOD TRIGLYCERIDES INCREASED 98 0.0055
437 MULTIPLE ORGAN DYSFUNCTION SYNDROME 157 0.0055
438 SQUAMOUS CELL CARCINOMA 52 0.0055
439 PLATELET COUNT INCREASED 72 0.0055
440 LOWER RESPIRATORY TRACT INFECTION 251 0.0055
441 DRUG PRESCRIBING ERROR 106 0.0055
442 TRANSIENT ISCHAEMIC ATTACK 186 0.0055
443 DRUG INTOLERANCE 532 0.0055
444 ASTHMA 621 0.0055
445 CARDIOTOXICITY 49 0.0055
446 HEMIPARESIS 93 0.0055
447 EPISTAXIS 410 0.0055
448 HAEMODIALYSIS 46 0.0055
449 FALL 1823 0.0055
450 INITIAL INSOMNIA 56 0.0055
451 HAEMOPTYSIS 152 0.0054
452 ELECTROCARDIOGRAM QT PROLONGED 196 0.0054
453 OESOPHAGITIS 59 0.0054
454 CANDIDA INFECTION 91 0.0054
455 SPINAL DISORDER 51 0.0054
456 HAEMODYNAMIC INSTABILITY 41 0.0054
457 COORDINATION ABNORMAL 75 0.0054
458 DIZZINESS POSTURAL 52 0.0054
459 NEPHROPATHY TOXIC 60 0.0053
460 HEPATIC ENZYME INCREASED 364 0.0053
461 PARKINSONISM 52 0.0053
462 ASTHENIA 1998 0.0053
463 NERVE COMPRESSION 49 0.0053
464 DISORIENTATION 210 0.0053
465 GASTROINTESTINAL HAEMORRHAGE 442 0.0053
466 CHOLELITHIASIS 173 0.0053
467 INTERNATIONAL NORMALISED RATIO INCREASED 150 0.0053
468 BREAST PAIN 56 0.0052
469 HEART RATE INCREASED 518 0.0052
470 DYSPNOEA 2947 0.0052
471 OSTEOPENIA 79 0.0052
472 TOXIC EPIDERMAL NECROLYSIS 79 0.0052
473 COLITIS ULCERATIVE 232 0.0052
474 LIMB DISCOMFORT 160 0.0052
475 PULMONARY MASS 77 0.0052
476 PRODUCT ODOUR ABNORMAL 54 0.0052
477 CARDIOMYOPATHY 76 0.0051
478 RED BLOOD CELL COUNT DECREASED 147 0.0051
479 CATARACT 306 0.0051
480 TORSADE DE POINTES 40 0.0051
481 LEUKOPENIA 255 0.0051
482 ARTERIAL OCCLUSIVE DISEASE 40 0.0051
483 PURPURA 45 0.0051
484 STENT PLACEMENT 41 0.0051
485 TYPE 2 DIABETES MELLITUS 171 0.0051
486 BLOOD ALKALINE PHOSPHATASE INCREASED 126 0.0051
487 SKIN LACERATION 55 0.0051
488 RESPIRATORY DISORDER 151 0.0050
489 MYELODYSPLASTIC SYNDROME 73 0.0050
490 GAIT INABILITY 168 0.0050
491 PHOTOSENSITIVITY REACTION 83 0.0050
492 VITAMIN D DEFICIENCY 49 0.0050
493 ERECTILE DYSFUNCTION 129 0.0050
494 PANCYTOPENIA 280 0.0050
495 ABDOMINAL DISCOMFORT 840 0.0050
496 RIB FRACTURE 103 0.0050
497 DECREASED APPETITE 1163 0.0050
498 HEART RATE IRREGULAR 113 0.0050
499 ABDOMINAL PAIN 1153 0.0050
500 GLYCOSYLATED HAEMOGLOBIN INCREASED 125 0.0049
501 CHEST DISCOMFORT 505 0.0049
502 HAEMATEMESIS 125 0.0049
503 BALANCE DISORDER 426 0.0049
504 INFUSION RELATED REACTION 326 0.0049
505 GINGIVAL BLEEDING 67 0.0049
506 ROTATOR CUFF SYNDROME 63 0.0049
507 FLUID RETENTION 249 0.0049
508 DISTURBANCE IN ATTENTION 263 0.0049
509 EAR DISCOMFORT 50 0.0049
510 PSYCHOLOGICAL TRAUMA 42 0.0049
511 HAIR DISORDER 40 0.0048
512 GENERALISED OEDEMA 60 0.0048
513 HEPATIC CIRRHOSIS 91 0.0048
514 AGRANULOCYTOSIS 90 0.0048
515 BLADDER DISORDER 48 0.0048
516 MYASTHENIA GRAVIS 39 0.0048
517 ILEUS 60 0.0048
518 BLOOD CHOLESTEROL INCREASED 225 0.0048
519 JAUNDICE 129 0.0048
520 PNEUMONIA BACTERIAL 44 0.0048
521 PALPITATIONS 561 0.0048
522 MUSCLE RIGIDITY 57 0.0048
523 TACHYCARDIA 423 0.0048
524 LEUKOCYTOSIS 86 0.0047
525 BLOOD COUNT ABNORMAL 72 0.0047
526 FLATULENCE 269 0.0047
527 HAEMOGLOBIN DECREASED 487 0.0047
528 BLOOD URINE PRESENT 90 0.0047
529 POST PROCEDURAL HAEMORRHAGE 55 0.0047
530 THROMBOTIC MICROANGIOPATHY 46 0.0047
531 SECRETION DISCHARGE 59 0.0047
532 FACIAL PAIN 42 0.0047
533 PALLOR 128 0.0047
534 GAIT DISTURBANCE 900 0.0047
535 LOSS OF CONSCIOUSNESS 602 0.0047
536 ENCEPHALOPATHY 115 0.0047
537 PNEUMONIA 1515 0.0047
538 NASAL CONGESTION 274 0.0047
539 NEURALGIA 113 0.0046
540 LUNG INFILTRATION 41 0.0046
541 CONSTIPATION 1010 0.0046
542 RENAL DISORDER 215 0.0046
543 DELIRIUM 160 0.0046
544 CHROMATURIA 104 0.0046
545 LIMB INJURY 125 0.0046
546 NEUROPATHY PERIPHERAL 437 0.0046
547 HEAD INJURY 145 0.0046
548 FEELING COLD 127 0.0046
549 ALANINE AMINOTRANSFERASE INCREASED 279 0.0045
550 ARTHROPATHY 252 0.0045
551 ASPARTATE AMINOTRANSFERASE INCREASED 240 0.0045
552 MOVEMENT DISORDER 145 0.0045
553 APHASIA 136 0.0045
554 MENTAL STATUS CHANGES 125 0.0045
555 HEPATIC ENCEPHALOPATHY 42 0.0045
556 HAIR COLOUR CHANGES 56 0.0045
557 JOINT SWELLING 541 0.0045
558 COGNITIVE DISORDER 209 0.0045
559 GASTRIC ULCER 85 0.0045
560 PAIN IN EXTREMITY 1315 0.0045
561 GASTROINTESTINAL INFECTION 40 0.0045
562 SKIN HAEMORRHAGE 66 0.0044
563 DEPRESSED MOOD 235 0.0044
564 ABDOMINAL PAIN UPPER 915 0.0044
565 MYOCLONUS 53 0.0044
566 FULL BLOOD COUNT ABNORMAL 47 0.0044
567 BLOOD BILIRUBIN INCREASED 120 0.0044
568 HYPERBILIRUBINAEMIA 46 0.0044
569 PANCREATIC CARCINOMA 128 0.0044
570 COLD SWEAT 78 0.0044
571 LOCALISED INFECTION 107 0.0044
572 KNEE ARTHROPLASTY 93 0.0044
573 MOTOR DYSFUNCTION 45 0.0044
574 DEMENTIA 123 0.0044
575 WOUND 123 0.0044
576 DRY MOUTH 357 0.0044
577 CONFUSIONAL STATE 711 0.0044
578 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 211 0.0044
579 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 113 0.0044
580 DIARRHOEA 2830 0.0044
581 SEPSIS 488 0.0044
582 PNEUMONITIS 119 0.0044
583 THIRST 78 0.0044
584 TRANSAMINASES INCREASED 97 0.0044
585 DYSPHAGIA 414 0.0044
586 MOBILITY DECREASED 313 0.0044
587 HYPERHIDROSIS 561 0.0044
588 ORAL HERPES 85 0.0044
589 BLOOD THYROID STIMULATING HORMONE INCREASED 40 0.0043
590 COMA 207 0.0043
591 CLOSTRIDIUM DIFFICILE COLITIS 46 0.0043
592 ORAL PAIN 97 0.0043
593 BACK PAIN 1006 0.0043
594 POOR QUALITY SLEEP 93 0.0043
595 FIBROMYALGIA 105 0.0043
596 HERPES ZOSTER 248 0.0043
597 LYMPHOPENIA 61 0.0043
598 PETECHIAE 45 0.0043
599 LIVER DISORDER 191 0.0043
600 MUSCULAR WEAKNESS 488 0.0043
601 NECK PAIN 239 0.0043
602 RESPIRATORY DISTRESS 118 0.0043
603 SPEECH DISORDER 224 0.0043
604 GASTROINTESTINAL PAIN 47 0.0043
605 MEDICATION ERROR 236 0.0042
606 VIRAL INFECTION 141 0.0042
607 DRY THROAT 43 0.0042
608 SKIN CANCER 91 0.0042
609 PNEUMOTHORAX 67 0.0042
610 NERVOUSNESS 220 0.0042
611 WEIGHT FLUCTUATION 44 0.0042
612 ADRENAL INSUFFICIENCY 51 0.0042
613 WOUND INFECTION 46 0.0042
614 BRAIN OEDEMA 53 0.0042
615 SWOLLEN TONGUE 131 0.0042
616 PARALYSIS 60 0.0042
617 OROPHARYNGEAL PAIN 388 0.0042
618 SKIN INFECTION 47 0.0042
619 SEPTIC SHOCK 181 0.0042
620 METASTASES TO BONE 68 0.0041
621 ATELECTASIS 40 0.0041
622 MENTAL DISORDER 180 0.0041
623 MUSCULOSKELETAL CHEST PAIN 64 0.0041
624 DYSGEUSIA 307 0.0041
625 RESPIRATORY FAILURE 301 0.0041
626 HALLUCINATION, VISUAL 87 0.0041
627 ASCITES 121 0.0041
628 TREATMENT NONCOMPLIANCE 225 0.0041
629 EYE PAIN 232 0.0041
630 MEMORY IMPAIRMENT 564 0.0041
631 DYSPHONIA 240 0.0041
632 RASH MACULO-PAPULAR 91 0.0041
633 NEOPLASM 47 0.0041
634 GASTRIC HAEMORRHAGE 47 0.0041
635 CYSTITIS 130 0.0041
636 CHOKING 79 0.0040
637 SINUSITIS 415 0.0040
638 LIGAMENT SPRAIN 40 0.0040
639 THROAT IRRITATION 181 0.0040
640 NEPHROLITHIASIS 185 0.0040
641 FATIGUE 3139 0.0040
642 BLOOD GLUCOSE INCREASED 759 0.0040
643 DEPRESSED LEVEL OF CONSCIOUSNESS 159 0.0040
644 MALAISE 1759 0.0040
645 PRODUCT ADMINISTRATION ERROR 81 0.0040
646 HEADACHE 2504 0.0040
647 TASTE DISORDER 81 0.0040
648 PYREXIA 1380 0.0040
649 HOT FLUSH 300 0.0040
650 HYPERSOMNIA 114 0.0040
651 MUSCLE SPASMS 728 0.0040
652 RENAL PAIN 42 0.0040
653 PERITONITIS 82 0.0040
654 THROMBOCYTOPENIA 442 0.0039
655 BONE PAIN 230 0.0039
656 ARTHRALGIA 1625 0.0039
657 COVID-19 PNEUMONIA 46 0.0039
658 MUCOSAL INFLAMMATION 102 0.0039
659 OSTEOPOROSIS 160 0.0039
660 NEOPLASM MALIGNANT 259 0.0039
661 HERNIA 75 0.0039
662 WEIGHT INCREASED 867 0.0039
663 GASTRIC CANCER 98 0.0039
664 NERVE INJURY 43 0.0039
665 LUNG DISORDER 189 0.0039
666 SCAR 66 0.0039
667 FACE OEDEMA 65 0.0039
668 DYSARTHRIA 145 0.0038
669 NIGHT SWEATS 124 0.0038
670 LYMPHOCYTE COUNT DECREASED 68 0.0038
671 PNEUMONIA ASPIRATION 96 0.0038
672 SNEEZING 86 0.0038
673 INTRAOCULAR PRESSURE INCREASED 49 0.0038
674 TRANSFUSION 40 0.0038
675 HAIR TEXTURE ABNORMAL 51 0.0038
676 HYPERCALCAEMIA 47 0.0038
677 JOINT RANGE OF MOTION DECREASED 51 0.0038
678 VISUAL IMPAIRMENT 470 0.0038
679 SKIN ULCER 98 0.0038
680 SINUS CONGESTION 51 0.0038
681 FULL BLOOD COUNT DECREASED 76 0.0038
682 COLORECTAL CANCER 180 0.0038
683 CARDIAC ARREST 311 0.0038
684 HEPATIC CYTOLYSIS 48 0.0038
685 ECZEMA 197 0.0038
686 SOMNOLENCE 757 0.0038
687 IMMUNODEFICIENCY 56 0.0038
688 EAR PAIN 73 0.0038
689 LYMPHOMA 58 0.0037
690 BLOOD GLUCOSE FLUCTUATION 41 0.0037
691 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 87 0.0037
692 PANIC ATTACK 136 0.0037
693 RHINORRHOEA 241 0.0037
694 METASTASES TO CENTRAL NERVOUS SYSTEM 48 0.0037
695 ABDOMINAL DISTENSION 388 0.0037
696 WHITE BLOOD CELL COUNT INCREASED 142 0.0037
697 VISION BLURRED 508 0.0037
698 PLATELET COUNT DECREASED 394 0.0037
699 MYOCARDIAL INFARCTION 643 0.0037
700 HYPOAESTHESIA 551 0.0037
701 GASTROINTESTINAL DISORDER 329 0.0037
702 MUSCULOSKELETAL PAIN 192 0.0037
703 INSOMNIA 976 0.0037
704 NAUSEA 2899 0.0037
705 PULMONARY EMBOLISM 348 0.0037
706 ULCER 58 0.0036
707 CHILLS 426 0.0036
708 INFLUENZA 405 0.0036
709 FOETAL EXPOSURE DURING PREGNANCY 295 0.0036
710 MUSCULOSKELETAL DISORDER 69 0.0036
711 PRODUCT TASTE ABNORMAL 49 0.0036
712 LIVER FUNCTION TEST ABNORMAL 105 0.0036
713 VASCULITIS 42 0.0036
714 DYSSTASIA 105 0.0036
715 FEELING ABNORMAL 861 0.0036
716 IRRITABLE BOWEL SYNDROME 77 0.0036
717 HEPATIC FUNCTION ABNORMAL 134 0.0036
718 INTERNAL HAEMORRHAGE 41 0.0036
719 TREMOR 594 0.0036
720 IMPAIRED HEALING 117 0.0036
721 PHOTOPHOBIA 67 0.0036
722 HYPERSENSITIVITY 661 0.0036
723 VOMITING 1669 0.0035
724 FEELING HOT 217 0.0035
725 SKIN LESION 97 0.0035
726 MUSCULOSKELETAL STIFFNESS 309 0.0035
727 FEELING JITTERY 67 0.0035
728 TENDONITIS 54 0.0035
729 AMNESIA 226 0.0035
730 LIVER INJURY 85 0.0035
731 DIABETIC KETOACIDOSIS 83 0.0035
732 MADAROSIS 40 0.0034
733 CEREBROVASCULAR ACCIDENT 582 0.0034
734 IMPAIRED DRIVING ABILITY 39 0.0034
735 STOMATITIS 208 0.0034
736 NASOPHARYNGITIS 631 0.0034
737 ERYTHEMA 701 0.0034
738 RHEUMATOID ARTHRITIS 387 0.0034
739 SWELLING 319 0.0034
740 HYPOXIA 120 0.0034
741 AGEUSIA 85 0.0034
742 ILLNESS 351 0.0034
743 DEAFNESS 89 0.0034
744 RENAL CANCER 162 0.0034
745 HALLUCINATION 256 0.0034
746 CELLULITIS 171 0.0034
747 DIPLOPIA 88 0.0034
748 SKIN DISORDER 113 0.0034
749 NEUTROPHIL COUNT DECREASED 138 0.0034
750 HEPATIC FAILURE 102 0.0034
751 BODY TEMPERATURE INCREASED 69 0.0034
752 ATAXIA 40 0.0034
753 KIDNEY INFECTION 66 0.0034
754 ABDOMINAL PAIN LOWER 85 0.0034
755 LUNG INFECTION 52 0.0033
756 TOXICITY TO VARIOUS AGENTS 564 0.0033
757 ACUTE RESPIRATORY DISTRESS SYNDROME 59 0.0033
758 CARDIAC DISORDER 311 0.0033
759 ANXIETY 945 0.0033
760 DIALYSIS 47 0.0033
761 PRESCRIBED UNDERDOSE 66 0.0033
762 PROSTATE CANCER 266 0.0033
763 RASH PRURITIC 179 0.0033
764 FLUID OVERLOAD 48 0.0033
765 LETHARGY 189 0.0033
766 HAEMORRHAGE INTRACRANIAL 49 0.0033
767 LACRIMATION INCREASED 99 0.0033
768 SWELLING FACE 213 0.0033
769 DRY EYE 163 0.0033
770 BLINDNESS UNILATERAL 46 0.0033
771 FEBRILE NEUTROPENIA 215 0.0032
772 DEPRESSION 736 0.0032
773 HEPATOTOXICITY 72 0.0032
774 POST PROCEDURAL COMPLICATION 62 0.0032
775 APATHY 47 0.0032
776 LIP SWELLING 107 0.0032
777 PAIN IN JAW 91 0.0032
778 RESPIRATORY TRACT CONGESTION 51 0.0032
779 CONDITION AGGRAVATED 976 0.0032
780 UPPER RESPIRATORY TRACT INFECTION 148 0.0032
781 SPINAL FRACTURE 64 0.0032
782 HYPOAESTHESIA ORAL 48 0.0032
783 ANOREXIA 41 0.0032
784 SKIN DISCOLOURATION 146 0.0032
785 BURNING SENSATION 222 0.0032
786 DISCOMFORT 192 0.0031
787 BACK DISORDER 51 0.0031
788 PULMONARY ARTERIAL HYPERTENSION 45 0.0031
789 DRUG ERUPTION 55 0.0031
790 PAIN 1902 0.0031
791 COVID-19 543 0.0031
792 INTENTIONAL PRODUCT USE ISSUE 271 0.0031
793 CYTOKINE RELEASE SYNDROME 62 0.0031
794 MASS 43 0.0031
795 HYPOACUSIS 132 0.0031
796 FUNGAL INFECTION 102 0.0031
797 DISEASE RECURRENCE 145 0.0030
798 BLISTER 171 0.0030
799 JOINT INJURY 65 0.0030
800 PRURITUS 1168 0.0030
801 THERAPEUTIC PRODUCT EFFECT DECREASED 136 0.0030
802 UPPER LIMB FRACTURE 60 0.0030
803 VISUAL ACUITY REDUCED 100 0.0030
804 THROMBOSIS 242 0.0030
805 BRAIN FOG 47 0.0030
806 AGITATION 220 0.0030
807 DRUG INEFFECTIVE 3934 0.0030
808 RASH MACULAR 104 0.0030
809 ALOPECIA 582 0.0030
810 ILL-DEFINED DISORDER 180 0.0030
811 GENERALISED TONIC-CLONIC SEIZURE 49 0.0030
812 FEEDING DISORDER 60 0.0030
813 EYE SWELLING 110 0.0030
814 EYE DISORDER 97 0.0029
815 EMOTIONAL DISTRESS 355 0.0029
816 ANHEDONIA 77 0.0029
817 DEEP VEIN THROMBOSIS 190 0.0029
818 THROAT TIGHTNESS 79 0.0029
819 EYE IRRITATION 168 0.0029
820 NEUTROPENIA 396 0.0029
821 INTENTIONAL DOSE OMISSION 83 0.0029
822 ECONOMIC PROBLEM 44 0.0029
823 DELUSION 45 0.0029
824 INTESTINAL OBSTRUCTION 109 0.0029
825 HIP FRACTURE 93 0.0029
826 SINUS DISORDER 57 0.0029
827 PANCREATITIS 152 0.0029
828 PHARYNGEAL OEDEMA 44 0.0029
829 RESTLESS LEGS SYNDROME 52 0.0029
830 ABASIA 70 0.0028
831 GASTROENTERITIS VIRAL 51 0.0028
832 EATING DISORDER 60 0.0028
833 RETCHING 60 0.0028
834 HEPATITIS 72 0.0028
835 HIP ARTHROPLASTY 43 0.0028
836 ORAL DISCOMFORT 39 0.0028
837 SENSORY DISTURBANCE 45 0.0028
838 FRACTURE 53 0.0028
839 RASH 1214 0.0028
840 PARAESTHESIA 437 0.0028
841 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
842 INFECTION 397 0.0027
843 WHITE BLOOD CELL COUNT DECREASED 295 0.0027
844 DERMATITIS 57 0.0027
845 PLASMA CELL MYELOMA 106 0.0027
846 NIGHTMARE 94 0.0027
847 TREATMENT FAILURE 225 0.0027
848 HYPOPHAGIA 69 0.0027
849 STEVENS-JOHNSON SYNDROME 60 0.0027
850 ACUTE MYELOID LEUKAEMIA 42 0.0027
851 THERAPY NON-RESPONDER 121 0.0027
852 PRURITUS GENERALISED 58 0.0027
853 PSORIASIS 348 0.0027
854 COAGULOPATHY 44 0.0026
855 LUNG NEOPLASM MALIGNANT 108 0.0026
856 GASTRIC DISORDER 90 0.0026
857 BLADDER CANCER 154 0.0026
858 OCULAR HYPERAEMIA 124 0.0026
859 OFF LABEL USE 2271 0.0026
860 OSTEONECROSIS OF JAW 64 0.0026
861 HAEMORRHAGE 268 0.0026
862 PERICARDITIS 43 0.0026
863 URTICARIA 428 0.0026
864 LABORATORY TEST ABNORMAL 75 0.0025
865 CARDIO-RESPIRATORY ARREST 106 0.0025
866 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 456 0.0025
867 BONE DISORDER 46 0.0025
868 ANAPHYLACTIC SHOCK 65 0.0025
869 BLOOD GLUCOSE DECREASED 121 0.0025
870 BACTERIAL INFECTION 47 0.0025
871 BREAST CANCER FEMALE 66 0.0025
872 RASH ERYTHEMATOUS 118 0.0025
873 INTENTIONAL PRODUCT MISUSE 216 0.0025
874 INCREASED APPETITE 47 0.0025
875 PRODUCT USE ISSUE 460 0.0024
876 EYE PRURITUS 82 0.0024
877 DYSKINESIA 99 0.0024
878 TOOTHACHE 44 0.0024
879 PRODUCT AVAILABILITY ISSUE 55 0.0024
880 ROAD TRAFFIC ACCIDENT 101 0.0024
881 CYTOMEGALOVIRUS INFECTION 40 0.0024
882 EAR INFECTION 64 0.0024
883 MALIGNANT NEOPLASM PROGRESSION 246 0.0024
884 THINKING ABNORMAL 44 0.0024
885 INFLUENZA LIKE ILLNESS 193 0.0023
886 LOWER LIMB FRACTURE 45 0.0023
887 FLUSHING 236 0.0023
888 DRY SKIN 309 0.0023
889 PRODUCT USE IN UNAPPROVED INDICATION 569 0.0023
890 THERAPEUTIC RESPONSE DECREASED 139 0.0023
891 PREMATURE BABY 69 0.0023
892 GLOSSODYNIA 51 0.0023
893 PSORIATIC ARTHROPATHY 92 0.0023
894 OSTEOMYELITIS 41 0.0023
895 IRRITABILITY 135 0.0022
896 NEOPLASM PROGRESSION 78 0.0022
897 GALLBLADDER DISORDER 40 0.0022
898 LIVER FUNCTION TEST INCREASED 48 0.0022
899 MUSCLE TWITCHING 51 0.0022
900 SKIN FISSURES 43 0.0022
901 ABNORMAL DREAMS 60 0.0022
902 JOINT STIFFNESS 57 0.0022
903 SKIN EXFOLIATION 183 0.0022
904 SURGERY 127 0.0022
905 CONJUNCTIVITIS 40 0.0022
906 NERVOUS SYSTEM DISORDER 67 0.0021
907 TOOTH DISORDER 47 0.0021
908 ANAPHYLACTIC REACTION 116 0.0021
909 NEEDLE ISSUE 61 0.0021
910 MOUTH ULCERATION 44 0.0021
911 BLINDNESS 85 0.0021
912 RASH GENERALISED 54 0.0021
913 SYSTEMIC LUPUS ERYTHEMATOSUS 74 0.0021
914 PAIN OF SKIN 56 0.0021
915 ACTIVITIES OF DAILY LIVING IMPAIRED 41 0.0021
916 OVERDOSE 446 0.0021
917 CLOSTRIDIUM DIFFICILE INFECTION 45 0.0021
918 EPILEPSY 63 0.0021
919 SEIZURE 238 0.0021
920 PRODUCT DOSE OMISSION ISSUE 604 0.0021
921 UNDERDOSE 149 0.0020
922 UNEVALUABLE EVENT 154 0.0020
923 THERAPY INTERRUPTED 145 0.0020
924 THERAPEUTIC RESPONSE UNEXPECTED 89 0.0020
925 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 141 0.0020
926 PRODUCT PRESCRIBING ISSUE 43 0.0020
927 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 399 0.0020
928 DRUG EFFECT DECREASED 105 0.0019
929 THERAPY CESSATION 99 0.0019
930 ADVERSE DRUG REACTION 172 0.0019
931 COMPLETED SUICIDE 158 0.0019
932 BREAST CANCER 176 0.0019
933 DRUG EFFECT INCOMPLETE 68 0.0019
934 STAPHYLOCOCCAL INFECTION 61 0.0018
935 RASH PAPULAR 41 0.0018
936 DRUG ADMINISTRATION ERROR 56 0.0018
937 FEMUR FRACTURE 56 0.0018
938 DISEASE PROGRESSION 212 0.0018
939 PRODUCT DOSE OMISSION 116 0.0018
940 SUICIDAL IDEATION 161 0.0018
941 RESPIRATORY ARREST 48 0.0017
942 PRODUCT DOSE OMISSION IN ERROR 49 0.0017
943 EMOTIONAL DISORDER 53 0.0017
944 PRODUCT QUALITY ISSUE 232 0.0017
945 MATERNAL EXPOSURE DURING PREGNANCY 152 0.0017
946 INJECTION SITE MASS 63 0.0017
947 DRUG RESISTANCE 43 0.0017
948 WITHDRAWAL SYNDROME 69 0.0016
949 DRUG ABUSE 136 0.0016
950 EXPIRED PRODUCT ADMINISTERED 54 0.0016
951 MIGRAINE 155 0.0016
952 AGGRESSION 81 0.0016
953 SEDATION 42 0.0016
954 ANGER 54 0.0016
955 INCORRECT DOSE ADMINISTERED 364 0.0016
956 SKIN IRRITATION 73 0.0016
957 EXPOSURE DURING PREGNANCY 98 0.0016
958 DRUG DOSE OMISSION 258 0.0016
959 ABNORMAL BEHAVIOUR 61 0.0015
960 INJECTION SITE PRURITUS 100 0.0015
961 OSTEONECROSIS 49 0.0015
962 ACCIDENTAL OVERDOSE 54 0.0015
963 INJECTION SITE RASH 45 0.0015
964 PSYCHOTIC DISORDER 43 0.0015
965 CONVULSION 83 0.0014
966 ADVERSE EVENT 133 0.0014
967 HOSPITALISATION 221 0.0014
968 INJURY 100 0.0014
969 INJECTION SITE ERYTHEMA 176 0.0014
970 VAGINAL HAEMORRHAGE 61 0.0014
971 THERAPEUTIC RESPONSE SHORTENED 46 0.0014
972 DEATH 1172 0.0014
973 MULTIPLE SCLEROSIS RELAPSE 93 0.0014
974 INJECTION SITE BRUISING 106 0.0013
975 DERMATITIS ATOPIC 70 0.0013
976 INJECTION SITE HAEMORRHAGE 106 0.0013
977 ACNE 100 0.0013
978 INJECTION SITE SWELLING 100 0.0013
979 DEVICE MALFUNCTION 90 0.0013
980 CRYING 46 0.0013
981 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 63 0.0011
982 INJECTION SITE PAIN 335 0.0011
983 MULTIPLE SCLEROSIS 52 0.0011
984 EXTRA DOSE ADMINISTERED 42 0.0010
985 DEVICE ISSUE 92 0.0010
986 ACCIDENTAL EXPOSURE TO PRODUCT 98 0.0009
987 INJECTION SITE REACTION 65 0.0009
988 DRUG WITHDRAWAL SYNDROME 76 0.0009
989 NO ADVERSE EVENT 144 0.0008
990 SKIN BURNING SENSATION 50 0.0007
991 PRODUCT STORAGE ERROR 49 0.0006
992 DRUG DOSE OMISSION BY DEVICE 40 0.0005
993 DRUG DEPENDENCE 52 0.0003